BridgeMD
New treatment option for Breast Carcinoma
Official title High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
ClinicalTrials.gov ID: NCT06835426
What this study is testing
- What it's testing
- These are patients in whom a benign or malignant tumor was recorded requiring surgery. During that surgery, the surgeon will cut away the tumor as part of the treatment of the disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- able to understand treatment protocol and informed consent form
- estimated by the investigator to be compliant for study participation 1\. Fulfilling all group-specific
- confirmed breast cancer with an indication to undergo breast conserving surgery
- confirmed prostate cancer with an indication to undergo resective surgeryprostatectomy;
- confirmed thyroid lesion with an indication to undergo resective surgery;
You likely can't join if
- general or local contra-indications for resective surgery;
- in case of FDG-based PET tracers: a blood glucose level over 200 mg/dL on the day of surgery;
- pregnancy or lactation;
- participation in other clinical studies with a radiation exposure of more than 1 mSv in the past year.
See the full eligibility criteria
- able to understand treatment protocol and informed consent form
- estimated by the investigator to be compliant for study participation 1\. Fulfilling all group-specific
- confirmed breast cancer with an indication to undergo breast conserving surgery
- confirmed prostate cancer with an indication to undergo resective surgeryprostatectomy;
- confirmed thyroid lesion with an indication to undergo resective surgery;
- confirmed parathyroid adenoma with an indication to undergo resective surgery;
- suspected basal cell carcinoma, squamous cell carcinoma or melanoma with an indication to undergo resective surgery;
- suspected lesion in genitourinary sites (including bladder cancer, renal pelvis and ureter carcinoma, adrenal cortical carcinoma and renal cell carcinoma) with an indication to undergo resective surgery;
- suspected lesion in the head \& neck region with an indication to undergo resective surgery;
- confirmed primary or secondary hepatobiliary cancer with an indication to undergo resective surgery;
- patients undergoing biopsy after metabolic active lesions were detected on a PET scan.
- suspected neuro-endocrine malignancies with an indication to undergo resective surgery.
- suspected brain tumor with an indication to undergo resective surgery.
- Suspected malignant and benign gastrointestinal lesions with an indication to undergo resective surgery.
- suspected malignant thoracovascular lesions with an indication to undergo resective surgery B.
- general or local contra-indications for resective surgery;
- in case of FDG-based PET tracers: a blood glucose level over 200 mg/dL on the day of surgery;
- pregnancy or lactation;
- participation in other clinical studies with a radiation exposure of more than 1 mSv in the past year.
The study team makes the final eligibility decision.
Where it's taking place
- Ghent, Oost Vlaanderen, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ghent, Oost Vlaanderen, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.